Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$956,216
-$198,152 QoQ
Shares Held
39,710
-3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,351
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RESOURCES MANAGEMENT CORP /CT/ /ADV holds $58,736,749 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
85,694 | $21,564,038 | |
| 2 | JNJ |
Johnson & Johnson
|
57,899 | $14,704,609 | |
| 3 | LLY |
ELI LILLY & Co
|
6,910 | $8,288,061 | |
| 4 | MRK |
Merck & Co., Inc.
|
58,507 | $7,518,149 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
20,373 | $2,573,924 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,375 | $1,577,347 | |
| 7 | AMGN |
Amgen Inc
|
3,432 | $1,242,795 | |
| 8 | PFE |
Pfizer Inc
This page
|
39,710 | $956,216 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $956,216 | 39,710 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,154,368 | 41,110 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,296,194 | 52,056 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,531,246 | 60,096 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,832,931 | 75,616 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $1,990,152 | 78,538 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $2,349,894 | 88,575 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,844,946 | 98,305 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $3,293,246 | 117,700 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,447,826 | 124,246 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,034,947 | 140,151 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,346,440 | 161,183 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $6,265,457 | 170,814 | Shares | Sole | 2023-08-16 | |
| 2023-03-31 | $255 | 1,525 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,208,494 | 179,713 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $7,839,516 | 179,148 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $9,408,930 | 179,457 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $9,297,788 | 179,598 | Shares | Sole | 2022-05-20 | |
| 2021-12-31 | $10,738,124 | 181,848 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $8,032,547 | 186,760 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,471,023 | 190,782 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $7,645,979 | 211,040 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $8,173,770 | 222,053 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $8,245,197 | 224,665 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $7,345,800 | 224,642 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $7,365,434 | 225,657 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||